Your session is about to expire
← Back to Search
Hearing Aid
Experimental for Neonatal Hearing Loss
N/A
Waitlist Available
Research Sponsored by Sonova AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 28, visit 3
Awards & highlights
No Placebo-Only Group
Summary
This trial tests different noise reduction settings and Bluetooth streaming methods in hearing aids for kids and teens aged 10-17. It aims to find out which settings help them hear better and which Bluetooth methods they prefer.
Eligible Conditions
- Neonatal Hearing Loss
- Hearing Loss
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 28, visit 3
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 28, visit 3
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Subjective Rating of Listening Effort Questionnaire
Secondary study objectives
Physical Response Time
Speech Reception Threshold
Subjective Preference Questionnaire for Hearing Aid Noise Reduction Settings
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Participants will be fit with a commercially available hearing aid and tested using various strengths of the noise reduction feature.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phonak Hearing Aid
2023
N/A
~20
Find a Location
Who is running the clinical trial?
Sonova AGLead Sponsor
80 Previous Clinical Trials
1,910 Total Patients Enrolled
Vanderbilt UniversityOTHER
710 Previous Clinical Trials
6,143,284 Total Patients Enrolled
1 Trials studying Neonatal Hearing Loss
236 Patients Enrolled for Neonatal Hearing Loss
Share this study with friends
Copy Link
Messenger